Vision Problems in Endometrial Cancer: What to Watch For and When to Seek Urgent Care

People living with endometrial cancer can experience vision or eye symptoms for several reasons: the cancer itself rarely causes paraneoplastic eye syndromes, treatments (chemotherapy and immunotherapy) can affect the eyes and optic nerve, and unrelated but serious eye emergencies can happen at any time. Recognizing warning signs early and knowing when to act can protect sight and, in rare cases, be life‑saving. ^[1] Eye symptoms such as pain, redness, sudden vision changes, double vision, or sensitivity to light may indicate treatment side effects (including inflammation inside the eye), infection, or other serious causes that benefit from prompt evaluation. ^{[2] [3]}

---

Why vision monitoring matters

Certain endometrial cancer treatments (for example, combinations using carboplatin and paclitaxel with immunotherapy such as durvalumab or dostarlimab) are associated with ocular side effects including eye pain, red or swollen eyes, blurred or changed vision, dry or watery eyes, light sensitivity, changes in color vision, and inflammation such as uveitis or optic neuritis. ^{[4] [5] [2]} Immune‑related inflammation of the eye (uveitis, iritis) and optic nerve (optic neuritis) are uncommon but potentially serious and typically require prompt medical treatment to prevent vision loss. ^[2] Paraneoplastic retinopathy an autoimmune condition causing rapid visual decline has been reported, albeit rarely, in people with endometrial cancer. ^[6]

---

At‑a‑Glance Checklist: Vision and Eye Symptoms to Track

Use this checklist during treatment and follow‑up; share it with your oncology and eye teams if any item appears or changes.

• Eye pain (new or worsening). ^[4]
• Red, sore, or swollen eyes. ^[4]
• Blurry vision or any change in vision (including difficulty focusing). ^[4]
• Sudden decrease in vision in one or both eyes. ^[3]
• Double vision (seeing two images). ^[3]
• Changes in color vision. ^[4]
• Light sensitivity (photophobia). ^[4]
• Watery, gritty, or very dry eyes; burning or irritation. ^[4]
• New floaters, spots, or “cobwebs” in vision, especially if sudden or many. ^[7]
• Flashes of light or a “curtain”/shadow over part of vision. ^[7]
• Headache with eye pain, nausea, or vomiting. ^[3]
• Eyelid swelling, discharge, or crusting. ^[3]
• Eye redness with severe discomfort or sudden vision change. ^[8]
• Any new neurological symptoms with vision changes (confusion, weakness, trouble speaking). ^[9]

---

When to call urgently vs. go to the emergency department

Some symptoms can wait for a same‑day call to your oncology clinic or eye doctor, while others warrant immediate emergency care. When in doubt, err on the side of urgent evaluation.

Call your oncology team or eye care professional the same day

• New or worsening eye pain, redness, or swelling without sudden vision loss. ^[4]
• New blurry vision or change in vision that is mild and not rapidly progressing. ^[4]
• Light sensitivity, gritty/dry/watery eyes that are new or bothersome. ^[4]
• Changes in color vision. ^[4]
  These may reflect treatment‑related effects (including immune‑related eye inflammation) that need prompt assessment and often respond to early therapy. ^[2]

Go to the emergency department now

• Any sudden loss of vision (partial or complete) in one or both eyes. ^[3]
• Double vision that starts suddenly or is associated with other neurological symptoms. ^[3]
• Severe eye pain with headache, nausea, or vomiting. ^[3]
• New large number of floaters, flashes of light, or a curtain/shadow over vision (possible retinal tear/detachment). ^[7]
• Painful red eye with rapid vision change. ^[8]
• Chemical exposure to the eye or penetrating/embedded object in the eye. ^[3]
  These features signal possible emergencies (retinal detachment, acute glaucoma, optic neuritis, severe uveitis, stroke, or ocular trauma) where quick treatment can preserve vision. ^{[3] [8]}

---

How cancer therapies can affect the eyes

• Platinum/taxane chemotherapy with immunotherapy (durvalumab or dostarlimab) can cause eye pain, red/swollen eyes, blurred or changed vision, color vision change, dry or watery eyes, and light sensitivity; these programs advise reporting eye symptoms promptly and, in some instances, seeking emergency care if severe. ^{[4] [5]}
• Immune checkpoint inhibitors can trigger immune‑related ocular toxicities, including uveitis/iritis, episcleritis, blepharitis, conjunctivitis, tear duct problems, optic neuritis, and photophobia; early recognition and treatment (often with corticosteroids) can reduce the risk of lasting vision loss. ^[2]
• A recently reported case links dostarlimab with bilateral panuveitis causing marked vision drop, which improved with topical and oral steroids illustrating the need for rapid ophthalmology evaluation when vision acutely worsens on immunotherapy. ^[10]

---

Rare but important: cancer‑associated retinopathy

Paraneoplastic retinopathies are rare autoimmune syndromes where the immune system attacks retinal proteins, leading to rapid vision decline and visual field loss; they have been described in endometrial cancer. ^[6] Features can include decreased visual acuity, narrowed visual fields, and abnormal electroretinogram findings; early recognition and treatment may help stabilize vision. ^[11]

---

Practical steps for users with endometrial cancer

• Keep a simple symptom diary noting the day, time, eye involved, and how the symptom changes. Report patterns or worsening promptly. ^[4]
• Before starting immunotherapy or new chemotherapy, ask your team about baseline and follow‑up eye checks; having an ophthalmologist familiar with treatment‑related ocular issues can speed care if symptoms appear. ^[12]
• Use preservative‑free artificial tears for dryness or irritation if advised, and wear sunglasses outdoors to reduce light sensitivity and irritation from wind or sun. ^[4]
• If you experience any of the emergency features above, seek care immediately rather than waiting for a routine visit. ^{[3] [8]}

---

Summary table: Symptoms and urgency

Vision/eye symptom	Likely significance (varies by context)	Action and timing
Eye pain, redness, swelling	Treatment‑related irritation or inflammation (e.g., uveitis)	Call oncology/eye clinic same day; urgent if severe or with vision drop. [4] [2]
Blurry or changed vision	Dry eye, medication effect, or ocular inflammation	Same‑day call; emergency if sudden or severe. [4] [3]
Sudden loss of vision (any part)	Retinal detachment, optic neuritis, stroke, severe uveitis	Emergency department now. [3]
Double vision	Neurologic or ocular emergency	Emergency department now. [3]
Many new floaters, flashes, curtain over vision	Possible retinal tear/detachment	Emergency department now. [7]
Light sensitivity (photophobia)	Ocular surface irritation, uveitis	Same‑day call; urgent if with pain/vision change. [4] [2]
Color vision change	Optic nerve/retinal involvement, medication effect	Same‑day call. [4]
Severe eye pain with headache/nausea	Acute glaucoma or other emergency	Emergency department now. [3]

---

Key takeaways

• A simple checklist covering pain, redness, blurriness, sudden vision loss, double vision, floaters/flashes, light sensitivity, and color vision changes helps catch problems early. ^{[4] [3] [7]}
• Immunotherapy combinations used in endometrial cancer can cause eye inflammation, including uveitis and optic neuritis, which may threaten vision without prompt care. ^[2]
• Sudden or severe symptoms especially vision loss, double vision, many new floaters with flashes, a curtain over vision, or severe painful red eye require immediate emergency evaluation. ^{[3] [7] [8]}

---